Sandoz announced the launch of valsartan tablets, an authorized generic version of Diovan tablets which is used for the treatment of high blood pressure.
Ohm Labs, a wholly owned subsidiary of Ranbaxy Labs, on Friday announced that it received approval from the Food and Drug Administration to manufacture and market valsartan tablets in 40 mg, 80 mg, 160 mg and 320 mg dosage strengths.
The Food and Drug Administration has given tentative approval to a generic drug for treating hypertension, according to agency records.
A court has ruled in favor of Indian generic drug maker Ranbaxy Labs in a case concerning a generic blood pressure drug, the legal firm representing the drug maker said.
The Food and Drug Administration has approved a generic hypertension drug made by Mylan, the company said.
Par Pharmaceutical Cos. has contracted with AstraZeneca to distribute an authorized generic version of a drug used to treat high blood pressure, Par said.
Generic drug maker Sandoz has launched an authorized generic version of a drug used to treat hypertension.
The Food and Drug Administration has approved a blood pressure medication made by Mylan.
A Takeda drug designed to treat hypertension was statistically superior to another drug combination in reducing systolic blood pressure among patients in a 10-week, late-stage clinical trial.
A class of drugs commonly used to control blood pressure does not increase patients’ risk of developing cancer, according to the Food and Drug Administration.
A blood pressure drug made by Swiss drug maker Novartis has won an award from the Healthcare Compliance Packaging Council.
Drug maker Takeda has filed for regulatory approval of a drug to treat hypertension, the company said Wednesday.
An investigational treatment made by Daiichi Sankyo for hypertension significantly lowers blood pressure in patients...
Daniel Vasella will step down as CEO of Novartis to focus on his position as...